Market Indices
Latest News
 |
Citigroup analyst issues OUTPERFORM recommendation for OCUL on February 17,...
February 17, 2026 OCUL -21.23% |
| ||
| ||
| ||
|
Price Targets
from UBS issued a price target of $76.00 for SEZL on 2026-02-17 13:38:36.The adjusted price target was set to $76.00.At the time of the announcement, SEZL was...
February 17, 2026 SEZL -0.03%
from Jefferies issued a price target of $12.00 for FHTX on 2026-02-17 11:16:44.The adjusted price target was set to $12.00.At the time of the announcement, FHTX was...
February 17, 2026 FHTX 0.72%
Matt Koranda from Roth Capital issued a price target of $5.00 for LCUT on 2026-02-13 14:36:41.The adjusted price target was set to $5.00.At the time of the announcement,
February 13, 2026 LCUT 4.09%
Gus Richard from Northland Securities issued a price target of $24.00 for AIP on 2026-02-13 13:50:04.The adjusted price target was set to $24.00.At the time of the announcement,
February 13, 2026 AIP -4.13%
from Craig-Hallum issued a price target of $15.00 for CMPX on 2026-02-13 13:13:31.The adjusted price target was set to $15.00.At the time of the announcement, CMPX was...
February 13, 2026 CMPX 1.83%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| MAPSW WM Technology Inc | 0.01
36.21% | ||||||||||||||||||
| AIXI Xiao-I Corporation | 0.28
21.22% | ||||||||||||||||||
| DHX DHI Group, Inc. | 2.84
18.33% | ||||||||||||||||||
| PRPH ProPhase Labs, Inc. | 0.18
17.65% | ||||||||||||||||||
| VGAS Verde Clean Fuels, Inc. | 1.08
13.59% | ||||||||||||||||||
| XOSWW Xos Equity Warrants | 0.00
12.82% | ||||||||||||||||||
| MREO Mereo BioPharma Group plc | 0.42
11.91% | ||||||||||||||||||
| KPTI Karyopharm Therapeutics I | 9.57
11.54% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -4.13%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 3.15%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.94%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.19%